Summary & Overview
HCPCS Q4135: Mediskin per Square Centimeter, Dermal Substitute Supply
HCPCS Level II code Q4135 designates Mediskin billed per square centimeter as an add-on supply reported in addition to a primary procedure. This code matters nationally because it standardizes reporting for a unit-priced dermal substitute product used in wound care and dermatologic procedures, impacting coding consistency, coverage determinations, and payment calculations across payers. Accurate use of the code affects provider billing, payer adjudication, and patient cost-sharing.
Key payers discussed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical context for use of a per-square-centimeter dermal substitute, payer coverage considerations, typical sites of service where the supply is used, and common modifiers associated with billing this add-on supply. The publication also summarizes benchmark measures for utilization and reimbursement practices where available and flags areas where policy clarification or documentation standards are commonly required.
The report is intended for billing professionals, coding compliance staff, revenue cycle teams, and clinical managers seeking a national view of how an add-on dermal substitute supply is coded and handled by major payers, along with practical context for documentation and claims submission. Data not available in the input is noted where applicable.
Billing Code Overview
HCPCS Level II code Q4135 represents Mediskin billed per square centimeter as an add-on supply that is reported separately in addition to a primary procedure. The code is used to report the unit-based charge for Mediskin product rather than a procedure itself.
Service type: Topical biologic/dermal substitute supply (per sq cm), adjunct to primary wound or dermatologic procedure.
Typical site of service: Ambulatory surgical centers, hospital outpatient departments, physician offices, and wound care clinics where a primary procedure addressing skin or soft-tissue defects is performed.
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult with a chronic full-thickness or partial-thickness cutaneous wound (for example, a non-healing diabetic foot ulcer, venous stasis ulcer, or large traumatic skin loss) who presents to an outpatient wound care clinic or ambulatory surgical center. After initial evaluation including wound measurement, cleansing, debridement as indicated, and assessment of vascular status, the clinician elects to apply a topical skin substitute product billed with Q4135 (Mediskin) as an adjunct to standard wound care. The procedure is performed in a procedure room or clinic treatment area; local anesthesia may be used. The workflow typically includes wound bed preparation (sharp or autolytic debridement), measurement of wound size in square centimeters for Q4135 supply calculation, application of the Mediskin product to the prepared wound, appropriate dressing application, and documentation of product type, quantity (cm2), wound measurements, provider performing the service, and any concurrent procedures. Follow-up visits document graft/treatment incorporation and may include additional applications if clinically indicated.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 | Increased procedural services | Use when work or resources are substantially greater than typical for application due to complex wound preparation or prolonged procedure time. |